Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPACK Block With Adductor Canal Block in Total Knee Arthroplasty
NCT07449442Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- Mar 2026
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in knee osteoarthritis (OA) (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Systemic Inflammation Response Index at 12 hours. Started Mar 2026; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07449442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07449442.